Abstract
Research work was implemented to describe the kinetics of cell growth, substrate utilization and product formation using a mutant strain of Streptomyces hygroscopicus NTG-30-27 in a 3-L bioreactor under optimized condition. Various substrate inhibition mathematical models were applied and it was found that the cell growth and substrate utilization kinetic data fitted well to those models. Andrew’s kinetic model was fitted very well (R2 = 0.998) with our experimental data among different models tested for analysis whereas Luedeking–Piret model suggested that our product is mixed growth associated. The values for maximum specific growth rate (µmax), doubling time (td), saturation constant (KS), inhibition constant (KI) and yield coefficient (YX/S) were found to be 0.03985 h−1, 17.16 h, 2.076 g/l, 0.009 g/l and 0.290 g g−1. Final rapamycin yield with mutant strain was found to be 531.4 mg/l on its 5th day of fermentation which is 6.7-fold higher than the wild type (79.31 mg/l). The effect of aeration on rapamycin production was studied by batch fermentation in a stirred tank reactor (STR) using S. hygroscopicus NTG-30-27. Dynamic behaviour and aeration efficiency of the reactor, as well as rheology pattern of the fermentation broth, were determined by calculating volumetric mass transfer coefficient (KLa) of the process using “Dynamic gassing out method”. KLa was found to be 54.53 h−1 which is quite significant for rapamycin production. Further purification and structural analysis of the extracted sample were carried out by liquid chromatography–mass spectrophotometry (LC–MS) technique in positive ionization mode and molecular mass was found to be 936 D. Finally, 90.62% purified rapamycin was obtained from the study.
Similar content being viewed by others
Abbreviations
- dP/dt :
-
Production rate (mg/l-hr−1)
- K i :
-
Inhibition coefficient (g/l)
- K L a :
-
Volumetric mass transfer coefficient (hr−1)
- K S :
-
Saturation constant (g/l)
- M :
-
Cell maintenance coefficient
- P 0, P, P max :
-
Product concentration at 0th h of fermentation (mg/l), product concentration at any time of fermentation (mg/l), maximum product concentration at particular fermentation time (mg/l)
- R 2 :
-
Regression coefficient
- S 0, S :
-
Initial substrate concentration (g/l), limited substrate concentration (g/l)
- t :
-
Incubation time (hr)
- t d :
-
Doubling time of cell (hr)
- LPM:
-
Liter per minute
- mTOR:
-
Mechanistic target of rapamycin
- vvm:
-
Volume of air per volume of fermentation media per minute (m3)
- X 0, X, X max :
-
Initial cell mass concentration (g/l), cell mass concentration at any time of fermentation (g/l), maximum attainable call mass concentration (g/l)
- Y X/S :
-
Growth yield coefficient per unit substrate consumed (g/g)
- µ, µ max :
-
Specific growth rate (hr−1), maximum specific growth rate (hr−1)
- α :
-
Growth-associated product formation coefficient (mg/g)
- β :
-
Non-growth-associated product formation coefficient (mg/g-hr−1)
References
Abdel-Fattah YR (2008) Non-conventional method for evaluation and optimization of medium components for rapamycin production by Streptomyces hygroscopicus. Res J Microbiol 3:405–413
Bandyopadhyay B, Humphrey AE, Taguchi H (1967) Dynamic measurement of the volumetric oxygen transfer coefficient in fermentation systems. Biotechnol Bioeng 9:533–544
Barquilla A, Crespo JL, Navarro M (2008) Rapamycin inhibits trypanosome cell growth by preventing TOR complex 2 formation. Proc Natl Acad Sci 105:14579–14584
Benkortbi O, Hanini S, Bentahar F (2007) Batch kinetics and modelling of pleuromutilin production by Pleurotus mutilis. Biochem Eng J 36:14–18
Çalik P, Bilir E, Çalik G, Özdamar TH (2003) Bioreactor operation parameters as tools for metabolic regulations in fermentation processes: influence of pH conditions. Chem Eng Sci 58:759–766
Calne R, Lim S, Samaan A, Collier DSJ, Pollard S, White D, Thiru S (1989) Rapamycin for immunosuppression in organ allografting. Lancet 334:227
Chater KF (1984) Morphological and physiological differentiation in Streptomyces. Cold Spring Harbor Monogr Arch 16:89–115
Cheng YR, Hauck L, Demain AL (1995) Phosphate, ammonium, magnesium and iron nutrition of Streptomyces hygroscopicus with respect to rapamycin biosynthesis. J Ind Microbiol 14:424–427
Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB (1984) Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med 101:667–682
Cruz AJG, Silva AS, Araujo MLGC, Giordano RC, Hokka CO (1999) Estimation of the volumetric oxygen transfer coefficient (K L a) from the gas balance and using a neural network technique. Br J Chem Eng 16:179–183
Douros J, Suffness M (1981) New antitumor substances of natural origin. Cancer Treat Rev 8:63–87
Dutta S, Basak B, Bhunia B, Chakraborty S, Dey A (2014) Kinetics of rapamycin production by Streptomyces hygroscopicus MTCC 4003. 3 Biotech 4:523–531. https://doi.org/10.1007/s13205-013-0189-2
Dutta S, Basak B, Bhunia B, Sinha A, Dey A (2017) Approaches towards the enhanced production of Rapamycin by Streptomyces hygroscopicus MTCC 4003 through mutagenesis and optimization of process parameters by Taguchi orthogonal array methodology. World J Microbiol Biotechnol 33:90
Earla R, Cholkar K, Gunda S, Earla RL, Mitra AK (2012) Bioanalytical method validation of rapamycin in ocular matrix by QTRAP LC–MS/MS: Application to rabbit anterior tissue distribution by topical administration of rapamycin nanomicellar formulation. J Chromatogr B 908:76–86
Elibol M, Mavituna F (1999) A kinetic model for actinorhodin production by Streptomyces coelicolor A3 (2). Process Biochem 34:625–631
Gerson DF, Kole MM, Ozum B, Oguztoreli MN (1988) Substrate concentration control in bioreactors. Biotechnol Genet Eng Rev 6:67–150
Gopalakrishnan K, Venkatesan S, Low ESH, Hande M (2018) Effects of rapamycin on the mechanistic target of rapamycin (mTOR) pathway and telomerase in breast cancer cells. Mutat Res 836:103–113
Harrison DE et al (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392–395
High KP (1994) The antimicrobial activities of cyclosporine, FK506, and rapamycin. Transplantation 57:1689–1700
Jagannath S, Ramachandran KB (2010) Influence of competing metabolic processes on the molecular weight of hyaluronic acid synthesized by Streptococcus zooepidemicus. Biochem Eng J 48:148–158
Khan SA, Salloum F, Das A, Xi L, Vetrovec GW, Kukreja RC (2006) Rapamycin confers preconditioning-like protection against ischemia–reperfusion injury in isolated mouse heart and cardiomyocytes. J Mol Cell Cardiol 41:256–264
Kojima I, Cheng YR, Mohan V, Demain AL (1995) Carbon source nutrition of rapamycin biosynthesis in Streptomyces hygroscopicus. J Ind Microbiol 14:436–439
Lee MS, Kojima I, Demain AL (1997) Effect of nitrogen source on biosynthesis of rapamycin by Streptomyces hygroscopicus. J Ind Microbiol Biotechnol 19:83–86
Lu W, Fan J, Wen J, Xia Z, Caiyin Q (2011) Kinetic analysis and modeling of daptomycin batch fermentation by Streptomyces roseosporus. Appl Biochem Biotechnol 163:453–462
Luedeking R, Piret EL (1959) A kinetic study of the lactic acid fermentation. Batch process at controlled pH. Biotechnol Bioeng 1:393–412
Nielsen S (2015) Food analysis laboratory manual, 2nd edn. Springer, US, pp 47–53
Okpokwasili GC, Nweke CO (2006) Microbial growth and substrate utilization kinetics. Afr J Biotechnol 5:305–317
Ozergin-Ulgen K, Mavituna F (1993) Actinorhodin production by Streptomyces coelicolor A3 (2): kinetic parameters related to growth, substrate uptake and production. Appl Microbiol Biotechnol 40:457–462
Puthli MS, Rathod VK, Pandit AB (2005) Gas–liquid mass transfer studies with triple impeller system on a laboratory scale bioreactor. Biochem Eng J 23:25–30
Riesenberg D, Bergter F (1979) Dependence of macromolecular composition and morphology of Streptomyces hygroscopicus on specific growth rate. Z allg Mikrobiol 19:415–430
Rosu F, Pirotte S, De Pauw E, Gabelica V (2006) Positive and negative ion mode ESI-MS and MS/MS for studying drug–DNA complexes. Int J Mass Spec 253:156–171
Sánchez L, Brana AF (1996) Cell density influences antibiotic biosynthesis in Streptomyces clavuligerus. Microbiology 142:1209–1220
Schindler PW, Zäuhner H (1973) Mode of action of the macrolide-type antibiotic, chlorothricin. FEBS J 39:591–600
Song X, Zhang Y, Xue J, Li C, Wang Z, Wang Y (2017) Enhancing nemadectin production by Streptomyces cyaneogriseus ssp. noncyanogenus through quantitative evaluation and optimization of dissolved oxygen and shear force. Bioresour technol 255:180–188
Stanbury PF, Whitaker A, Hall SJ (2013) Principles of fermentation technology. Elsevier, Oxford, UK
Steiner JP, Connolly MA, Valentine HL, Hamilton GS, Dawson TM, Hester L, Snyder SH (1997) Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat Med 3:421–428
Tan Y, Wang Z, Marshall KC (1996) Modeling substrate inhibition of microbial growth. Biotechnol Bioeng 52:602–608
Vezina C, Kudelski A, Sehgal S (1975) Rapamycin (AY-22, 989), a new antifungal antibiotic. J Antibiot 28:721–726
Vidal C, Kirchner G, Sewing KF (1998) Structural elucidation by electrospray mass spectrometry: an approach to the in vitro metabolism of the macrolide immunosuppressant SDZ RAD. J Am Soc Mass Spectrom 9:1267–1274
Wang YH, Zhang X (2007) Influence of agitation and aeration on growth and antibiotic production by Xenorhabdus nematophila. World J Microbiol Biotechnol 23:221–227
Wang X, Xia W, Li K, Zhang Y, Ge W, Ma C (2019) Rapamycin regulates cholesterol biosynthesis and cytoplasmic ribosomal proteins in hippocampus and temporal lobe of APP/PS1 mouse. J Neurol Sci. https://doi.org/10.1016/j.jns.2019.02.022
Wojarski J, Zeglen S, Ochman M, Karolak W (2018) Safety of Early Sirolimus Immunosuppression in Lung Transplantation. J Heart Lung Transplant 37:S455
Xu Z, Shen W, Chen X, Lin J, Cen P (2005) A high-throughput method for screening of rapamycin-producing strains of Streptomyces hygroscopicus by cultivation in 96-well microtiter plates. Biotechnol Lett 27:1135–1140
Yinliang C, Jeffrey K, Weimin H, Julia PC (1999) New process control strategy used in a rapamycin fermentation. Process Biochem 34:383–389
Zambry NS, Ayoib A, Noh NAM, Yahya ARM (2017) Production and partial characterization of biosurfactant produced by Streptomyces sp. R1. Bioprocess Biosyst Eng. https://doi.org/10.1007/s00449-017-1764-4
Zhu X, Zhang W, Chen X, Wu H, Duan Y, Xu Z (2010) Generation of high rapamycin producing strain via rational metabolic pathway based mutagenesis and further titer improvement with fed batch bioprocess optimization. Biotechnol Bioeng 107:506–515
Acknowledgements
This work was financially supported by the Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology, Govt. of India [Grant no.: 09/973(0012)/2014 EMR-I].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dutta, S., Bhunia, B., Raju, A. et al. Enhanced rapamycin production through kinetic and purification studies by mutant strain of Streptomyces hygroscopicus NTG-30-27. Chem. Pap. 73, 2053–2063 (2019). https://doi.org/10.1007/s11696-019-00767-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11696-019-00767-0